Omega Healthcare Investors, Inc. (NYSE:OHI) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Key Points

• Omega Healthcare Investors has received a consensus recommendation of "Moderate Buy" from analysts, with an average target price of $43.75 among twelve brokerages.
• In its most recent earnings report, Omega Healthcare posted an EPS of $0.77, exceeding estimates by 32 cents and reporting revenue of $235.60 million for the quarter.
• The company recently announced a quarterly dividend of $0.67 per share, yielding an annualized rate of 6.5%, though the payout ratio stands high at 165.43%.

Shares of Omega Healthcare Investors, Inc. (NYSE:OHI - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the ten ratings firms that are covering the stock, Marketbeat.com reports. Five equities research analysts have rated the stock with a hold recommendation and five have assigned a buy recommendation to the company. The average 12 month target price among brokers that have covered the stock in the last year is $43.75.

OHI has been the subject of several research reports. Mizuho lifted their price objective on shares of Omega Healthcare Investors from $37.00 to $40.00 and gave the stock a "neutral" rating in a research note on Thursday, September 11th. Royal Bank Of Canada boosted their target price on shares of Omega Healthcare Investors from $39.00 to $41.00 and gave the company a "sector perform" rating in a research report on Thursday, August 7th. Truist Financial boosted their target price on shares of Omega Healthcare Investors from $39.00 to $44.00 and gave the company a "hold" rating in a research report on Wednesday, September 3rd. Wells Fargo & Company boosted their target price on shares of Omega Healthcare Investors from $41.00 to $44.00 and gave the company an "overweight" rating in a research report on Wednesday, August 27th. Finally, Scotiabank boosted their target price on shares of Omega Healthcare Investors from $39.00 to $42.00 and gave the company a "sector perform" rating in a research report on Thursday, August 28th.

Insider Transactions at Omega Healthcare Investors

In related news, Director Lisa Egbuonu-Davis sold 2,500 shares of the business's stock in a transaction on Friday, August 8th. The shares were sold at an average price of $40.16, for a total transaction of $100,400.00. Following the completion of the transaction, the director directly owned 18,654 shares in the company, valued at $749,144.64. The trade was a 11.82% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.50% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in OHI. Wellington Management Group LLP increased its holdings in Omega Healthcare Investors by 16.6% in the fourth quarter. Wellington Management Group LLP now owns 340,073 shares of the real estate investment trust's stock valued at $12,872,000 after buying an additional 48,391 shares in the last quarter. GAMMA Investing LLC increased its holdings in Omega Healthcare Investors by 4,248.2% in the first quarter. GAMMA Investing LLC now owns 174,102 shares of the real estate investment trust's stock valued at $6,630,000 after buying an additional 170,098 shares in the last quarter. Rhumbline Advisers increased its holdings in Omega Healthcare Investors by 2.7% in the first quarter. Rhumbline Advisers now owns 797,469 shares of the real estate investment trust's stock valued at $30,368,000 after buying an additional 20,710 shares in the last quarter. NBC Securities Inc. purchased a new position in Omega Healthcare Investors in the first quarter valued at $29,000. Finally, Merit Financial Group LLC increased its holdings in Omega Healthcare Investors by 27.9% in the first quarter. Merit Financial Group LLC now owns 43,594 shares of the real estate investment trust's stock valued at $1,660,000 after buying an additional 9,519 shares in the last quarter. Hedge funds and other institutional investors own 65.25% of the company's stock.

Omega Healthcare Investors Trading Down 0.7%

NYSE:OHI opened at $41.55 on Tuesday. Omega Healthcare Investors has a 12 month low of $35.04 and a 12 month high of $44.42. The firm has a fifty day simple moving average of $41.19 and a 200-day simple moving average of $38.61. The company has a current ratio of 7.10, a quick ratio of 7.10 and a debt-to-equity ratio of 0.96. The company has a market capitalization of $12.26 billion, a P/E ratio of 25.65, a PEG ratio of 2.19 and a beta of 0.71.

Omega Healthcare Investors (NYSE:OHI - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The real estate investment trust reported $0.77 EPS for the quarter, topping the consensus estimate of $0.45 by $0.32. Omega Healthcare Investors had a net margin of 42.23% and a return on equity of 9.78%. The business had revenue of $235.60 million during the quarter, compared to the consensus estimate of $248.49 million. During the same period in the previous year, the firm posted $0.71 earnings per share. The business's revenue for the quarter was up 11.8% compared to the same quarter last year. Omega Healthcare Investors has set its FY 2025 guidance at 3.040-3.070 EPS. On average, equities research analysts anticipate that Omega Healthcare Investors will post 2.86 earnings per share for the current year.

Omega Healthcare Investors Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Monday, August 4th were given a dividend of $0.67 per share. The ex-dividend date was Monday, August 4th. This represents a $2.68 dividend on an annualized basis and a yield of 6.5%. Omega Healthcare Investors's payout ratio is currently 165.43%.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.